Vimarsana
Biggest News Aggregation in the World

Dror Harats News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dror Harats. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dror Harats Today - Breaking & Trending Today

NTBL Stock Price | Notable Labs Inc. Stock Quote (U.S.: Nasdaq) - Vimarsana News

NTBL Stock Price | Notable Labs Inc. Stock Quote (U.S.: Nasdaq)

NTBL | Complete Notable Labs Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

VBL Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update - Vimarsana News

VBL Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update

Merger with Notable expected to close in late September or October, subject to VBL’s S-4 registration statement being declared effective and shareholder approval $24.3 million in cash and cash equivalents as of June 30, 2023 MODI’IN, Israel and NEW YORK, Aug. 14, 2023 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT) (“VBL”), today announced financial results for the second quarter ended June 30, 2023, and provided a corporate update. “We continue to make good progress towards the closing of o

Source: yahoo.com
Vascular Biogenics (NASDAQ:VBLT) & Sigilon Therapeutics (NASDAQ:SGTX) Critical Survey - Vimarsana News

Vascular Biogenics (NASDAQ:VBLT) & Sigilon Therapeutics (NASDAQ:SGTX) Critical Survey

Vascular Biogenics (NASDAQ:VBLT – Get Rating) and Sigilon Therapeutics (NASDAQ:SGTX – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, profitability, earnings, institutional ownership and dividends. Volatility and Risk Vascular Biogenics has a beta of […]

VBL Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update - Vimarsana News

VBL Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update

MODI'IN, Israel and NEW YORK, May 15, 2023 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT) ("VBL"), today announced financial results for the first quarter ended March 31, 2023, and provided a corporate

VBL Therapeutics Reports Full Year 2022 Financial Results and Provides Corporate Update - Vimarsana News

VBL Therapeutics Reports Full Year 2022 Financial Results and Provides Corporate Update

MODIIN, Israel and NEW YORK, March 14, 2023 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT) (VBL), today announced financial results for the fiscal year ended December 31, 2022, and provided a corporate